Physician profile
Haripriya Maddur
NPI 1821207978
$3,457.02
in general payments reported to CMS, 2019-2025
7 companies · $32.27 in 2025
The $32.27 reported for 2025 was less than what a typical Transplant Hepatology provider received nationally (typical 2025 total: $508).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2022: $131 · 2023: $62.10 · 2024: $2,713 · 2025: $32.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,713 · Food and Beverage: $62.10 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,712.50 |
| Food and Beverage | $62.10 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,744.77 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $209.50 | 2019 | |
| Covidien Lp | $200.59 | 2019 | |
| Gilead Sciences, INC. | $125.47 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $94.77 | 2022 | |
| Abbvie INC. | $62.10 | 2023 | |
| Mallinckrodt Hospital Products INC. | $19.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haripriya Maddur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.